These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 3029612)

  • 1. [Clinical application of angiotensin converting enzyme inhibitors].
    Gotoh E; Ishii M
    Nihon Rinsho; 1989 Sep; 47(9):2047-51. PubMed ID: 2593277
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of inhibitor of angiotensin-converting enzyme on uric acid metabolism].
    Hosoya T; Kono H; Ikeda H; Ichida K; Miyahara T
    Nihon Jinzo Gakkai Shi; 1987 Oct; 29(10):1271-80. PubMed ID: 3326955
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Converting enzyme inhibitors in the treatment of arterial hypertension].
    Guedon J; Guedon-Moreau L
    Ann Cardiol Angeiol (Paris); 1988 Dec; 37(10):559-62. PubMed ID: 3223720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal transport of uric acid: influence of treatment by converting enzyme inhibitors].
    Labeeuw M; Pozet N; Hadj Aissa A; Laville M; Zech P
    Nephrologie; 1986; 7(5):214-5. PubMed ID: 3029612
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of angiotensin converting enzyme inhibitors in practice].
    Zschiedrich H
    Arzneimittelforschung; 1993 Feb; 43(2A):271-3. PubMed ID: 8498977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors.
    Lip GY; Ferner RE
    J Hum Hypertens; 1995 Sep; 9(9):711-5. PubMed ID: 8551483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of angiotensin converting enzyme inhibitors in nephrology].
    Stefanović V; Ivić M; Bogićević M
    Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.